OncoTargets and Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-07-31 Xiaoganglufei

投了一篇，审稿速度很快，审稿流程如下，仅供参考！
2020/06/03 投稿
2020/06/25 一审返回 accept with changes 3B
2020/07/17 返修
2020/07/27 接收 5A

225 25

展开25条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-07-25 ms4000000102523562

4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。

110 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-04-28 烁

4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗

110 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-08-05 ms4000000102523562

审稿速度:1.0
经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。

121 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-03-07 12197123m22暂无昵称

问一下，这个杂志需要原始数据吗？

133 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2022-04-07 ms3000000346482453

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：分子生物学
经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。

61 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2019-11-27 121c6f2dm84(暂无昵称)

请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗

154 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-11-24 tamgche

4E是个什么意思

86 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2019-12-05 海绵不是宝宝

请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到

128 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=805407, encodeId=56b280540e66, content=投了一篇，审稿速度很快，审稿流程如下，仅供参考！ 2020/06/03 投稿 2020/06/25 一审返回 accept with changes 3B 2020/07/17 返修 2020/07/27 接收 5A, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200731/0b88510053b3412fb53c2a1592a04746/651856a0b0b74148a42e8c58f9c83c11.jpg, createdBy=e2832444513, createdName=Xiaoganglufei, createdTime=Fri Jul 31 16:59:13 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804524, encodeId=e89780452426, content=4c持续了十天了，还没变化，有谁知道这个状态要持续多久，越迟是不是越危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Sat Jul 25 14:45:14 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589831, encodeId=4e0b589831dd, content=4cx已经两天了，也没有收到杂志社的邮件，有这样情况的吗？会接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2QqFxAjaiaYTDjfu1nJBq5OczQMaFo2cnQwO2sIdF45pxzTKPjk8z9aaicaQd9TgqgZvFEfBt3GNA/132, createdBy=fd7d5233968, createdName=烁, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806379, encodeId=a3ba8063e914, content=审稿速度:1.0 经验分享：历经2个月20多天终于接受了，一审20多天，返修后经历了二审，过程因为图片格式及修改回复格式不对，耽误一周，一共一个月4天接受，等的我心情都失望了，不过结局是好的，谢谢园子里的跟帖。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82165399155, createdName=ms4000000102523562, createdTime=Wed Aug 05 18:57:13 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586119, encodeId=9c4f586119e8, content=问一下，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48fc2266811, createdName=12197123m22暂无昵称, createdTime=Sat Mar 07 00:00:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209251, encodeId=13f6120925194, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：生物化学与分子生物学方向投稿，1月投出，1A了很久，后面就比较快了，一审一修及时完成，每天早晚查进度和检查最新邮件，4月初通知被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e15412151, createdName=ms3000000346482453, createdTime=Thu Apr 07 15:55:49 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580573, encodeId=d8a95805e39e, content=请问1E awaiting evaluation会持续多久啊，需要每个作者邮件同意吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901988, encodeId=c718901988f6, content=4E是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Tue Nov 24 22:47:52 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580967, encodeId=73ec58096e04, content=请问一下，投稿完后显示1DA，给我的邮件说会联系通讯作者确认给我funding approval才会进行下一步，但通讯作者一直没收到邮件，大概多久能收到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAAjrpSzJE6Xyy7q5V68KpfX7RYNic8SlCRTQL0BGmCsgH8sGdJ00GVhzggasxpIvaQf2WiaqTXBZQ/132, createdBy=83a85226258, createdName=海绵不是宝宝, createdTime=Thu Dec 05 00:00:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890732, encodeId=34e0890e3295, content=偏重的研究方向：肿瘤 经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib1Bj11FmTzGyBdTLBKlJ3Wsbib2dr4VVsZEefEpZT8BwwPAMnuAl96YQSyQkWNvkrY7Qpk0P68oSGg/0, createdBy=47d41615427, createdName=loost250, createdTime=Fri Oct 09 09:55:10 CST 2020, time=2020-10-09, status=1, ipAttribution=)]

2020-10-09 loost250

偏重的研究方向：肿瘤
经验分享：各位，8.25投稿，一周前进入Report sent to Editor-in-Chief，昨天变为 3cx The author is being contacted about the Editor-in-Chief's decision. 这是要拒的节奏吗

126 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务